The Share Price of Moderna (MRNA) Surged Over 10% in a Day

FXOpen

As shown by the chart of pharmaceutical company Moderna (MRNA):
→ 2024 was an extremely difficult year, with the price falling by approximately 60%;
→ however, in early 2025, we can see signs of renewed strength.

During yesterday’s session, Moderna’s (MRNA) share price rose by more than 10%, following news of the first death in the US from H5N1 bird flu. According to Barron’s, Moderna is one of the few pharmaceutical companies currently developing a vaccine for H5N1 bird flu, which is spreading rapidly across North America.

This brings back memories of 2020, when MRNA’s share price surged with a significant bullish gap on news of the COVID-19 vaccine trials.

Interestingly, the 2024 low is near the lower boundary of the 2020 gap, around the $37 level. From a technical analysis perspective, this “gap closure” could be viewed as a bullish sign, supported by yesterday’s price action.

Additionally:
→ there has been a breakout above the descending trend channel that dominated the end of 2024;
→ it is possible that price movements may form a new ascending channel (shown in blue);
→ further growth may be hindered by the psychological resistance level of $50.

According to TipRanks, analysts remain cautious about Moderna’s prospects:
→ only 4 out of 19 analysts recommend buying MRNA shares;
→ the average 12-month price target for MRNA is $62.

Buy and sell stocks of the world's biggest publicly-listed companies with CFDs on FXOpen’s trading platform. Open your FXOpen account now or learn more about trading share CFDs with FXOpen.

This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.

Stay ahead of the market!

Subscribe now to our mailing list and receive the latest market news and insights delivered directly to your inbox.

forex

Share CFD Trading with FXOpen

Share CFD Trading with FXOpen

Experience ECN technology for deep liquidity and light-speed trade execution

  • Trade with tight spreads
  • Take advantage of low commissions
  • Choose from 4 trading platforms: MT4, MT5, TradingView, or TickTrader
Learn more

Latest articles

Forex Analysis

Market Analysis: EUR/USD Gains Pace While USD/JPY Turns Red

EUR/USD started a decent upward move above the 1.0460 resistance. USD/JPY declined below 153.00 and is currently consolidating losses.

Important Takeaways for EUR/USD and USD/JPY Analysis Today

· The Euro found support and started a

Shares

Warren Buffett Sells Bank Shares

On Friday, Berkshire Hathaway’s 13F filing (a quarterly report required by the U.S. Securities and Exchange Commission from institutional investment managers overseeing more than $100 million in assets) revealed that Warren Buffett’s company:

→ Maintained its Apple (AAPL)

Forex Analysis

AUD/USD Trades Near Year’s High After RBA Decision

Today, the Reserve Bank of Australia (RBA) eased monetary policy, cutting the interest rate from 4.35% to 4.10%, according to Forex Factory.

As reported by Reuters:
→ This marks the first easing since the 2020 pandemic;
→ RBA Governor Michele

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 60% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.